|
|
Gene Symbol |
BMP15 |
|
Aliases |
GDF9B, ODG2, POF4 |
|
Entrez Gene ID |
|
|
Gene Name |
Bone morphogenetic protein 15 |
|
Chromosomal Location |
Xp11.22 |
|
HGNC ID |
|
|
Summary |
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate subunits of a disulfide-linked homodimer, or alternatively, a heterodimer, with the related protein, growth differentiation factor 9 (GDF9). This protein plays a role in oocyte maturation and follicular development, through activation of granulosa cells. Defects in this gene are the cause of ovarian dysgenesis and are associated with premature ovarian failure. [provided by RefSeq, Aug 2016]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Bone morphogenetic protein 15, growth/differentiation factor 9B |
|
Function |
May be involved in follicular development. Oocyte-specific growth/differentiation factor that stimulates folliculogenesis and granulosa cell (GC) growth |
|
|
|
|
|
UniProt |
|
|
Pfam |
Pfam Accession |
Pfam ID |
PF00019 |
TGF_beta |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000304845 |
|
P22309 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Endocrine System Diseases |
Ovarian Dysgenesis |
|
Ovarian Failure |
|
PCOS |
|
Neoplasms |
Ovarian Cancer |
|
Psychiatric/Brain disorders |
Intellectual Disability |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
|
|
c.34C>G, c.109G>C, c.169C>G, c.288G>C, and c.598C>T |
NIH criteria |
Direct
|
216 Chinese PCOS patients |
These results are the first to indicate that BMP15 gene mutations may be potentially associated with PCOS patients |
|
GDF9 |
|
|
|
Direct
|
28 women with PCOS, 26 controls |
The expression of these proteins is reduced and delayed in the early follicular stage in PCOS ovarian tissues, and these differences in expression may be associated with aberrant follicular development in patients with PCOS |
|
|
|
|